ftInvstr
HCG · Healthcare ₹589.35 -1.75% Mkt Cap ₹8799 Cr overvalued

HCG

Healthcare Medical Care Facilities
₹589.35
-1.75% today · 30d +0.11%
as of 2026-11-09
Price · Daily Candles
“HCG grapples with volatile profits despite revenue surge, DIIs slightly increase stake.”
Healthcare Global Enterprises, with a market cap of ₹9794 Cr, saw annual revenue climb 14.51% YoY to ₹2545 Cr for FY26, yet net profit plunged 53.35% YoY to ₹23 Cr. Quarterly net profit further declined 40.32% YoY to ₹4 Cr, resulting in a TTM PE of 669.39 and an ROE of 0.53% (from `display_ratios`).
BULL CASE
+Annual revenue for FY26 increased by 14.51% to ₹2545 Cr, demonstrating consistent top-line expansion.
+Quarterly operating profit grew by 19.15% YoY to ₹138 Cr, with OPM improving by 1.29 percentage points.
+Shareholding data shows Domestic Institutional Investors (DIIs) slightly increased their stake by 0.02 percentage points QoQ to 18.91%.
+ML sales growth predictions are strong, with sales_1y_recent_2y rank at 0.727 and sales_1y_stable_7y at 0.673.
BEAR CASE
−Net profit saw a significant annual decline of 53.35% YoY to ₹23 Cr and a quarterly decline of 40.32% YoY to ₹4 Cr.
−The TTM PE ratio stands at a high 669.39, significantly above peer average, suggesting a rich valuation.
−The Return on Capital Employed (ROCE) is 8.0%, which is considerably lower than sector leaders like Apollo Hospitals (20.26%) and NH (22.72%).
−ML predictions for free cash flow (FCF_1Y) are weak, with ranks at 0.285 for recent 2y, 0.01 for rolling 4y, and 0.046 for stable 7y.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹732 Cr
+13.13% YoY
NET PROFIT
₹9 Cr
-55.23% YoY
OPM
18.44%
-0.95pp YoY
EPS
₹0.32
PE 669.39
Intrinsic value · DCF ₹10.31 · Margin of safety -98.3% (overvalued) · FCF yield 0.63%
◇ Sector Position
HCG's TTM PE of 669.39 and ROCE of 8.0% position it significantly above the sector average PE, while lagging behind peers like APOLLOHOSP (PE 82.13, ROCE 20.26%), making it a high-valuation, lower-return outlier in the medical care facilities sector.
PEERPEROCE %
HCG669.398.0
APOLLOHOSP82.1320.26
MAXHEALTH67.0714.44
FORTIS94.2613.4
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
42
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth MUTED 49
Profitability DECENT 68
Technicals WEAK 40
Risk LOW 70
Key Stats
TTM PE
669.39
P/B
9.99
52W HIGH
₹804.65
OFF HIGH
-26.76%
MKT CAP
₹8799 Cr
◉ Active Signals
MACDNeutral5.1585
RSI(14)Neutral43.97
Street Consensus
9 analysts
₹774.0
mean target
Low ₹700.0Now ₹589.35High ₹920.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold HCG and at what entry.

Sign up freeSign in